Literature DB >> 16270158

Knockdown of human p53 gene expression in 293-T cells by retroviral vector-mediated short hairpin RNA.

De-Long Hao1, Chang-Mei Liu, Wen-Ji Dong, Huan Gong, Xue-Song Wu, De-Pei Liu, Chih-Chuan Liang.   

Abstract

RNA interference (RNAi) is an evolutionarily conserved process of gene silencing in multiple organisms, which has become a powerful tool for investigating gene function by reverse genetics. Recently, many groups have reported to use synthesized oligonucleotides or siRNA encoding plasmids to induce RNAi in mammalian cells by transfection, but this is still limited in its application, especially when it is necessary to generate long-term gene silencing in vivo. To circumvent this problem, retrovirus- or lentivirus-delivered RNAi has been developed. Here, we described two retroviral systems for delivering short hairpin RNA (shRNA) transcribed from the H1 promoter. The results showed that retroviral vector-mediated RNAi can substantially downregulate the expression of human p53 in 293-T cells. Furthermore, the retroviral vector-mediated RNAi in our transduction system can stably inactivate the p53 gene for a long time. Compared to shRNAs transcribed from the U6 promoter, H1-driven shRNA also dramatically reduced the expression of p53. The p53 downregulation efficiencies of H1- and U6-driven shRNAs were almost identical. The results indicate that retroviral vector-delivered RNAi would be a useful tool in functional genomics and gene therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16270158     DOI: 10.1111/j.1745-7270.2005.00107.x

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  4 in total

Review 1.  Concepts in in vivo siRNA delivery for cancer therapy.

Authors:  Christopher S Gondi; Jasti S Rao
Journal:  J Cell Physiol       Date:  2009-08       Impact factor: 6.384

2.  Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase I inhibitor or radiation.

Authors:  Francesco Sabbatino; Celeste Fusciello; Domenico Somma; Roberto Pacelli; Ravin Poudel; David Pepin; Antonio Leonardi; Chiara Carlomagno; Giuseppina Della Vittoria Scarpati; Soldano Ferrone; Stefano Pepe
Journal:  Cytometry A       Date:  2014-09-02       Impact factor: 4.355

3.  Evaluation of sgRNA target sites for CRISPR-mediated repression of TP53.

Authors:  Ingrid E B Lawhorn; Joshua P Ferreira; Clifford L Wang
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

4.  Adeno-associated virus type 8 vector-mediated expression of siRNA targeting vascular endothelial growth factor efficiently inhibits neovascularization in a murine choroidal neovascularization model.

Authors:  Tsutomu Igarashi; Noriko Miyake; Chiaki Fujimoto; Chiemi Yaguchi; Osamu Iijima; Takashi Shimada; Hiroshi Takahashi; Koichi Miyake
Journal:  Mol Vis       Date:  2014-04-11       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.